Ralf Altmeyer
Nowadays, Ralf Altmeyer is a widely discussed topic that has sparked the interest of many people around the world. Since its emergence, Ralf Altmeyer has generated controversy and debate, provoking conflicting opinions among experts and society in general. In this article, we will thoroughly explore everything related to Ralf Altmeyer, from its origin to its current implications, in order to provide a global and complete vision that allows a thorough understanding of this topic that is so relevant today.
Ralf Altmeyer | |
|---|---|
| Born | 8 July 1966 |
| Alma mater | State University of New York at Stony Brook Institut Pasteur, Paris University of Tübingen |
| Scientific career | |
| Fields | virology, influenza, SARS, infectious diseases, HIV, microbiology |
| Institutions | Institut Pasteur of Shanghai Griffith University of Australia |
Ralf M. Altmeyer is a German virologist who leads the Institut Pasteur of Shanghai,[1] a joint institute of the Chinese Academy of Sciences, Institut Pasteur and Shanghai Municipal Government, founded in 2004.
He completed his pre-doctoral studies at the State University of New York at Stony Brook, and holds a Ph. D. (1994) from Institut Pasteur in Paris, where he also completed his postdoctoral thesis on neuropathogenesis of HIV infections (1996).[citation needed]
His research interests including respiratory diseases, Hepatitis C, HIV, and focus on anti-infective therapeutic strategies.[citation needed]
During his career of fifteen years at Institut Pasteur and the Pasteur international network, Ralf Altmeyer held various management positions including the position of CEO of the HKU-Pasteur Research Centre in Hong Kong. From 2003 to 2006 Ralf Altmeyer was the architect of a successful restructuring and establishment of the organization's new strategy.[2]
He left Institut Pasteur in 2006 to become the President of CombinatoRx-Singapore,[3] the infectious disease subsidiary of CombinatoRx (NASDAQ:CRXX), established in 2005 in collaboration with Bio*One Capital in Singapore. Ralf Altmeyer left CombinatoRx-Singapore in summer 2009 subsequent to the acquisition of the company by Forma Therapeutics. In 2011, he founded Advance BioChina, a Shanghai-based incubator company that helps global biotech companies access the Chinese market.
Ralf Altmeyer also holds the position of adjunct professor at Griffith University of Australia, Institute of Glycomics.[4]
References
- ^ Official press release on the Chinese Academy of Sciences website - Feb 1, 2010 "IPS Appoints New Director General---Chinese Academy of Sciences". Archived from the original on 16 July 2011. Retrieved 9 February 2010.
- ^ Official statement on the HKU-PRC Research Centre - July 2006 Archived 2009-09-27 at the Wayback Machine
- ^ "Speaker list of the BioInvest Asia 2008 Forum". Archived from the original on 17 July 2011. Retrieved 9 February 2010.
- ^ List of staff at Institute of Glycomics of Griffith University Archived 2009-10-04 at the Wayback Machine
